The efficacy of the HIRMAb-GDNF fusion protein in experimental PD was tested in Rhesus monkeys, since the HIRMAb domain of the fusion protein cross-reacts with the insulin receptor in this primate (Pardridge et al., 1995). The gene discussed is INSR; the disease is Parkinson disease.